OMDA OMDA Share-Based Payment - Unrecognized Cost of Nonvested Awards

Share-Based Payment - Unrecognized Cost of Nonvested Awards at other companies

Ryan Specialty HoldingsRYAN

$223.55M+9.5%

10x Genomics, Inc.TXG

$19.87-29.9%

GitLabGTLB

$700K-95.8%

Open TextOTEX

$125.81M-15.8%

MarketAxessMKTX

$70.9M+3.2%

Oruka Therapeutics, Inc.ORKA

$84.1M—

Other financials

Income statement

See full

Revenue$78.0M+42.0%

Gross profit$48.7M+52.6%

Operating income-$4.8M+43.1%

Net income-$3.0M+68.6%

EPS (diluted)-$0.05+95.7%

Balance sheet

See full

Cash & equivalents$211.8M+257%

Total debt$30.0M—

Total equity$234.1M+160%

Total assets$302.8M—

Cash flow

See full

Operating cash flow-$11.8M+26.6%

CapEx$78.0K-75.2%

Free cash flow-$11.9M+27.5%

Valuation

See full

Market cap$1.11B+23.8%

P/S3.9×-0.4×

Profitability

See full

Gross margin66.3%+4.4pp

Operating margin-9.6%-4.0pp

Net margin-11.3%-4.6pp

FCF margin-40.8%—

Returns & leverage

See full

Return on equity26.8%—

Debt / equity0.1×—

Current ratio3.9×—

Where this comes from

Reported directly by OMDA in its filing.

Tagged under the XBRL concept us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions.

The official record: OMDA’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about OMDA's share-based payment - unrecognized cost of nonvested awards.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is OMDA's share-based payment - unrecognized cost of nonvested awards?: OMDA (OMDA) reported share-based payment - unrecognized cost of nonvested awards of $15.5M in Q1 2026.
What does share-based payment - unrecognized cost of nonvested awards mean?: This represents the total compensation expense for equity-based awards that has been granted but not yet recognized in the income statement because the vesting conditions have not been met. It serves as a forward-looking indicator of future non-cash compensation expenses. Investors use this to forecast the impact of stock-based compensation on future earnings.